PUMA BIOTECHNOLOGY, INC. Increase (Decrease) in Restricted Cash
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Increase (Decrease) in Restricted Cash of -$1.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-08-09
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was -$1.00K, a 200.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $1.00K, a 0.00% change year-over-year.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $1.00K.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for fiscal 2016 was $4.00K, a 99.87% decline from fiscal 2015.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for fiscal 2015 was $3.10M, a 309700.00% increase from fiscal 2014.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for fiscal 2014 was $1.00K, a 50.00% decline from fiscal 2013.
- PUMA BIOTECHNOLOGY, INC. increase (decrease) in restricted cash for fiscal 2013 was $2.00K, a 98.74% decline from fiscal 2012.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 3 month as first filed | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 6 month as first filed | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 9 month as first filed | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 12 month as first filed | Increase (Decrease) in Restricted Cash 16 month | Increase (Decrease) in Restricted Cash 18 month | Increase (Decrease) in Restricted Cash 21 month | Increase (Decrease) in Restricted Cash 25 month | Increase (Decrease) in Restricted Cash 27 month | Increase (Decrease) in Restricted Cash 30 month | Increase (Decrease) in Restricted Cash 33 month | Increase (Decrease) in Restricted Cash 36 month | Increase (Decrease) in Restricted Cash 39 month | Increase (Decrease) in Restricted Cash 42 month | Increase (Decrease) in Restricted Cash 45 month | Increase (Decrease) in Restricted Cash 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.00K 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-08-09 | $1.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||||||
| 2017-03-31 | -$1.00K 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $1.00K derived: sum of 3 quarters · filed 2018-03-09 | $2.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.00K derived: sum of 2 quarters · filed 2018-03-09 | $3.00K derived: sum of 3 quarters · filed 2018-03-09 | $4.00K 10-K · filed 2018-03-09 | ||||||||||||||||
| 2016-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.00K derived: sum of 2 quarters · filed 2017-11-09 | $3.00K 10-Q · filed 2017-11-09 | $4.00K derived: sum of 4 quarters · filed 2018-03-09 | ||||||||||||||||
| 2016-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.00K 10-Q · filed 2017-08-09 | $3.00K derived: sum of 3 quarters · filed 2018-03-09 | |||||||||||||||||
| 2016-03-31 | $1.00K 10-Q · filed 2017-05-10 | $2.00K derived: sum of 2 quarters · filed 2018-03-09 | ||||||||||||||||||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $3.10M 10-K · filed 2018-03-09 | ||||||||||||||||||
| 2015-09-30 | $3.10M 10-Q · filed 2016-11-09 | |||||||||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.00K 10-K · filed 2017-03-01 | |||||||||||||||||
| 2014-09-30 | $1.00K derived: 10-Q 48 month − 10-Q 45 month · filed 2014-11-10 | $1.00K 10-Q · filed 2015-11-09 | $1.22M 10-Q · filed 2014-11-10 | |||||||||||||||||
| 2014-06-30 | $1.21M 10-Q · filed 2014-08-11 | |||||||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 42 month − 10-K 39 month · filed 2014-05-12 | $1.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.00K derived: sum of 4 quarters · filed 2016-02-29 | $1.21M 10-Q · filed 2014-05-12 | |||||||||||||||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.00K derived: sum of 2 quarters · filed 2016-02-29 | $1.00K derived: sum of 3 quarters · filed 2016-02-29 | $2.00K 10-K · filed 2016-02-29 | $1.21M 10-K · filed 2014-03-03 | |||||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $1.00K 10-Q · filed 2014-11-10 | $1.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.21M 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.00K 10-Q · filed 2014-08-11 | $1.00K derived: sum of 3 quarters · filed 2015-03-02 | $3.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.21M 10-Q · filed 2013-08-06 | |||||||||||||||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-12 | $1.00K derived: sum of 2 quarters · filed 2015-03-02 | $3.00K derived: sum of 3 quarters · filed 2015-03-02 | $159.00K derived: sum of 4 quarters · filed 2015-03-02 | $1.21M 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.00K derived: sum of 2 quarters · filed 2015-03-02 | $158.00K derived: sum of 3 quarters · filed 2015-03-02 | $159.00K 10-K · filed 2015-03-02 | $1.21M 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $158.00K derived: sum of 2 quarters · filed 2013-11-12 | $159.00K 10-Q · filed 2013-11-12 | $158.50K 10-Q · filed 2012-11-14 | $1.21M 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $157.00K 10-Q · filed 2013-08-06 | $156.89K 10-Q · filed 2012-08-14 | $1.21M 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | $1.00K 10-Q · filed 2013-05-09 | $526.00 10-Q · filed 2012-05-15 | $1.05M 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2011-12-31 | $1.05M 10-K · filed 2014-03-03 | $1.05M 10-K · filed 2012-03-29 | $1.05M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |